Cambrex
CBM | US
Overview
Corporate Details
- ISIN(s):
- US1320111073
- LEI:
- 4Q9DLX2VIFGJMOYJ4Y35
- Country:
- United States of America
- Address:
- N/A
- Website:
- https://www.cambrex.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Cambrex filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cambrex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cambrex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea
348080
South Korea
348080
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
United States of America
RANI
United States of America
RANI
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea
214260
South Korea
214260
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
United States of America
RAPP
United States of America
RAPP
Developing immune-targeting therapies for inflammatory and immunologic diseases.
United States of America
RAPT
United States of America
RAPT
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy
REC
Italy
REC
Develops oral drugs for GI, infectious diseases, and pandemic preparedness.
United States of America
RDHL
United States of America
RDHL
Develops TCM-based therapies for neurocognitive disorders like ADHD and ASD.
United States of America
RGC
United States of America
RGC
A biotech firm inventing, developing, and commercializing medicines for serious diseases.
United States of America
REGN
United States of America
REGN
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
United States of America
RGNX